Clinical features of non-alcoholic steatohepatitis in patients with different glycemic status

Introduction. NAFLD is an urgent health problem, its prevalence reaches 45%. NAFLD increases the risk of cardiovascular diseases by 3 times, the risk of death from them by 2 times and increases the risk of developing diabetes by 5 times. NAS occupies up to 20% of the structure of NAFLD and has a hig...

Full description

Bibliographic Details
Main Authors: A. A. Shipovskaya, I. V. Kurbatova, P. V. Selivyorstov, V. N. Marchenko, V. G. Radchenko, O. P. Dudanova
Format: Article
Language:Russian
Published: Remedium Group LLC 2021-05-01
Series:Медицинский совет
Subjects:
Online Access:https://www.med-sovet.pro/jour/article/view/6164
_version_ 1797841640842330112
author A. A. Shipovskaya
I. V. Kurbatova
P. V. Selivyorstov
V. N. Marchenko
V. G. Radchenko
O. P. Dudanova
author_facet A. A. Shipovskaya
I. V. Kurbatova
P. V. Selivyorstov
V. N. Marchenko
V. G. Radchenko
O. P. Dudanova
author_sort A. A. Shipovskaya
collection DOAJ
description Introduction. NAFLD is an urgent health problem, its prevalence reaches 45%. NAFLD increases the risk of cardiovascular diseases by 3 times, the risk of death from them by 2 times and increases the risk of developing diabetes by 5 times. NAS occupies up to 20% of the structure of NAFLD and has a high potential for progression, and the violation of endogenous glycemic regulation and the development of DM2 accelerates the rate of disease progression.The goal was to determine the frequency of development of prediabetes (PD) and type 2 diabetes mellitus (T2DM) in NASH patients and the effect of impaired glycemic status on the clinical features of NASH.Materials and methods: 211 NASH patients were examined: 148 (70.1%) men, 63 (29.9%) women, 48.3 ± 10.2 years old. The diagnosis was established on the basis of clinical, laboratory, ultrasound and histological data. By enzyme immunoassay were determined: TNF-α, cytokeratin-18 fragments (CKF-18), insulin; were calculated HOMA-IR and NAFLD fibrosis score (NAFLD FS).Results and discussion. PD was detected in 39 (18.5%) patients, T2DM - in 33 (15.6%) patients. In PD patients, in contrast to patients with normoglycemia, the following indicators were significantly higher: waist circumference (WC), body mass index (BMI), cholesterol levels (Ch), LDL, ESR, TNF-α, NAFLD FS and lower albumin and platelet levels. In patients with T2DM, in contrast to those with normoglycemia, the following indicators were significantly higher: WC, BMI, alanine aminotransferase, alkaline phosphatase (APh), Ch, ESR, CKF-18 and NAFLD FS. In T2DM patients in contrast to those with PD, the following indicators were significantly higher: aminotransferases, APh and lower albumin level.Conclusions. Prediabetes and T2DM were detected with almost the same frequency among patients with NASH – in 18.5% and 15.6%, respectively. Disturbance of glycemic status was associated with a significance increase in waist circumference, markers of inflammation, dyslipidemia, fibrosis, hepatocytic necrosis, apoptosis, intrahepatic cholestasis and a decrease in albumin level.
first_indexed 2024-04-09T16:35:39Z
format Article
id doaj.art-8bd5eb61b3154b809ea7780751d7e4dc
institution Directory Open Access Journal
issn 2079-701X
2658-5790
language Russian
last_indexed 2024-04-09T16:35:39Z
publishDate 2021-05-01
publisher Remedium Group LLC
record_format Article
series Медицинский совет
spelling doaj.art-8bd5eb61b3154b809ea7780751d7e4dc2023-04-23T06:56:56ZrusRemedium Group LLCМедицинский совет2079-701X2658-57902021-05-0105687410.21518/2079-701X-2021-5-68-745593Clinical features of non-alcoholic steatohepatitis in patients with different glycemic statusA. A. Shipovskaya0I. V. Kurbatova1P. V. Selivyorstov2V. N. Marchenko3V. G. Radchenko4O. P. Dudanova5Petrozavodsk State UniversityKarelian Research Centre of the Russian Academy of SciencesNorth-Western State Medical University named after I.I. MechnikovPavlov First Saint Petersburg State Medical UniversityMilitary Medical Academy named after S.M.KirovPetrozavodsk State UniversityIntroduction. NAFLD is an urgent health problem, its prevalence reaches 45%. NAFLD increases the risk of cardiovascular diseases by 3 times, the risk of death from them by 2 times and increases the risk of developing diabetes by 5 times. NAS occupies up to 20% of the structure of NAFLD and has a high potential for progression, and the violation of endogenous glycemic regulation and the development of DM2 accelerates the rate of disease progression.The goal was to determine the frequency of development of prediabetes (PD) and type 2 diabetes mellitus (T2DM) in NASH patients and the effect of impaired glycemic status on the clinical features of NASH.Materials and methods: 211 NASH patients were examined: 148 (70.1%) men, 63 (29.9%) women, 48.3 ± 10.2 years old. The diagnosis was established on the basis of clinical, laboratory, ultrasound and histological data. By enzyme immunoassay were determined: TNF-α, cytokeratin-18 fragments (CKF-18), insulin; were calculated HOMA-IR and NAFLD fibrosis score (NAFLD FS).Results and discussion. PD was detected in 39 (18.5%) patients, T2DM - in 33 (15.6%) patients. In PD patients, in contrast to patients with normoglycemia, the following indicators were significantly higher: waist circumference (WC), body mass index (BMI), cholesterol levels (Ch), LDL, ESR, TNF-α, NAFLD FS and lower albumin and platelet levels. In patients with T2DM, in contrast to those with normoglycemia, the following indicators were significantly higher: WC, BMI, alanine aminotransferase, alkaline phosphatase (APh), Ch, ESR, CKF-18 and NAFLD FS. In T2DM patients in contrast to those with PD, the following indicators were significantly higher: aminotransferases, APh and lower albumin level.Conclusions. Prediabetes and T2DM were detected with almost the same frequency among patients with NASH – in 18.5% and 15.6%, respectively. Disturbance of glycemic status was associated with a significance increase in waist circumference, markers of inflammation, dyslipidemia, fibrosis, hepatocytic necrosis, apoptosis, intrahepatic cholestasis and a decrease in albumin level.https://www.med-sovet.pro/jour/article/view/6164nonalcoholic steatohepatitisprediabetestype 2 diabetes mellitus
spellingShingle A. A. Shipovskaya
I. V. Kurbatova
P. V. Selivyorstov
V. N. Marchenko
V. G. Radchenko
O. P. Dudanova
Clinical features of non-alcoholic steatohepatitis in patients with different glycemic status
Медицинский совет
nonalcoholic steatohepatitis
prediabetes
type 2 diabetes mellitus
title Clinical features of non-alcoholic steatohepatitis in patients with different glycemic status
title_full Clinical features of non-alcoholic steatohepatitis in patients with different glycemic status
title_fullStr Clinical features of non-alcoholic steatohepatitis in patients with different glycemic status
title_full_unstemmed Clinical features of non-alcoholic steatohepatitis in patients with different glycemic status
title_short Clinical features of non-alcoholic steatohepatitis in patients with different glycemic status
title_sort clinical features of non alcoholic steatohepatitis in patients with different glycemic status
topic nonalcoholic steatohepatitis
prediabetes
type 2 diabetes mellitus
url https://www.med-sovet.pro/jour/article/view/6164
work_keys_str_mv AT aashipovskaya clinicalfeaturesofnonalcoholicsteatohepatitisinpatientswithdifferentglycemicstatus
AT ivkurbatova clinicalfeaturesofnonalcoholicsteatohepatitisinpatientswithdifferentglycemicstatus
AT pvselivyorstov clinicalfeaturesofnonalcoholicsteatohepatitisinpatientswithdifferentglycemicstatus
AT vnmarchenko clinicalfeaturesofnonalcoholicsteatohepatitisinpatientswithdifferentglycemicstatus
AT vgradchenko clinicalfeaturesofnonalcoholicsteatohepatitisinpatientswithdifferentglycemicstatus
AT opdudanova clinicalfeaturesofnonalcoholicsteatohepatitisinpatientswithdifferentglycemicstatus